Home > Insider Trading > Filing (0001192482-13-000241)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1361248	Tetralogic Pharmaceuticals Corp	TLOG	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1510184	L Andrew Pecora	C/O Tetralogic Pharmaceuticals Corp 343 Phoenixville Pike Malvern PA 19355		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-17	26,551	$7.00	42,727	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2013-12-17	16,055	$0.00	58,782	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2013-12-17	5,887	$7.00	64,669	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2013-12-17	161	$6.40	64,830	No	4	X	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	X	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Convertible Preferred Stock	Disposition	2013-12-17	16,055	$0.00	16,055	$0.00
Common Stock	Convertible Notes	Disposition	2013-12-17	5,887	$0.00	5,887	$7.00
Common Stock	Series C Warrants	Disposition	2013-12-17	161	$0.00	161	$6.40

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	X	Indirect

Footnotes

Shares of Series C Convertible Preferred Stock were automatically converted to the same number of shares of Common Stock at the time of the Company's initial public offering on December 17, 2013.
The Convertible Notes and Accrued Interest automatically converted into Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering, at the initial public offering price of $7.00 per share, which occurred on December 17, 2013.
The warrants were automatically exercised immediately prior to the closing of the Issuer's initial public offering for a number of shares of common stock equal to the warrant amount divided by $6.4022 and net exercised at the initial public offering price of $7.00 per share.
Held by Pecora & Co., LLC.. The reporting person is the Chairman of Pecora & Company, LLC and has voting and investment power with respect to such shares held by Pecora & Co., LLC.